S. Korea's top pharmaceutical firms spend over 100 bln won each in H1 for R&D: data
--------------------------------------------------------------------
Source: South Korea
Published: 2026-08-23 12:32 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Science, Health, Property, Asia, South Korea, Drugs, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
SEOUL, Aug. 23 (Yonhap) -- South Korea's major pharmaceutical companies spent around 100 billion won (US$72.13 million) each in the first half for the research and development (R&D) of new drugs, data showed Sunday, in an apparent bid to secure future growth engines.
--------------------------------------------------------------------